Israeli pharmaceutical giant Teva has announced that the American Food and Drugs Administration (FDA) has granted approval for Synribo, an injectable drug for treating leukemia. The company says that the drug will soon be available for prescription.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Elbit Sells Air Defense System To Foreign Client For $50M
April 30, 2024
Facebook comments